NeoGenomics (NASDAQ:NEO) Reaches New 1-Year High at $20.75

Shares of NeoGenomics, Inc. (NASDAQ:NEO – Get Free Report) hit a new 52-week high during mid-day trading on Thursday . The stock traded as high as $20.75 and last traded at $20.55, with a volume of 845796 shares traded. The stock had previously closed at $19.24. Analysts Set New Price Targets Several equities research analysts […]

Related Keywords

United States ,Piper Sandler ,Aliciac Olivo ,William Blair ,Nasdaq ,Highmark Wealth Management ,Pharma Services ,Neogenomics Inc ,Bluepath Capital Management ,Morgan Stanley ,Goldman Sachs Group ,Coppell Advisory Solutions ,Clinical Services ,Tower Research Capital ,Neogenomics Company Profile ,Securities Exchange Commission ,Get Free Report ,General Counsel Alicia ,Exchange Commission ,Path Capital Management ,Advisory Solutions ,Financial Advisors ,Research Capital ,Mark Wealth Management ,Neogenomics Daily ,Neogenomics ,Nasdaq Neo ,Neo ,Medical ,Stocks ,Technicals ,